• LJI scientists uncover the structure and function of Inmazeb, the first FDA-approved drug for Ebola virus infection

    Updated: 2023-01-30 21:30:56
    Inmazeb (REGN-EB3), developed by Regeneron, is a three-antibody cocktail designed to target the Ebola virus glycoprotein. The drug was first approved for clinical use in October 2020, but its exact mechanism of action has remained unclear.

  • Call for Nominations - Acoustical Society of America Science Communication Awards

    Updated: 2023-01-30 15:45:39
    The Acoustical Society of America offers Science Communication Awards in Acoustics to recognize excellence in the communication of acoustics-related topics to a popular audience. The 2023 award cycle will accept content created between Jan. 1, 2021, and Dec. 31, 2022; if you have seen, heard, or created something acoustics-related during this time frame, please nominate it! Each nominated entry will be judged according to its general accessibility, relevance to acoustics, accuracy, and quality. Nominations will be accepted until March 15, 2023.

Current Feed Items | Previous Months Items

Dec 2022 | Nov 2022 | Oct 2022 | Sep 2022 | Aug 2022 | Jul 2022